Uses of interleukin-2
US4908433A · kind A · utility
38Cited by
23References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1988 |
| Grant date | Mar 13, 1990 |
| Priority date | — |
| Expiry date | Jun 10, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Interleukin 2 (IL 2; T-cell growth factor), produced with and without costimulation by Burkitt's lympho This invention was made with support in part under Grants CA 08748, CA 22507, CA 25608, CA 20194, CA 21525, CA31525, PO1-CA-20194, AI 18 321-01, CA 23766 and CA 33050 awarded by the National Cancer Institute, National Institute of Health, DHEW. The government has certain rights in this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.